Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

British Journal of Cancer
L SharpH Comber

Abstract

Several colorectal cancer-screening tests are available, but it is uncertain which provides the best balance of risks and benefits within a screening programme. We evaluated cost-effectiveness of a population-based screening programme in Ireland based on (i) biennial guaiac-based faecal occult blood testing (gFOBT) at ages 55-74, with reflex faecal immunochemical testing (FIT); (ii) biennial FIT at ages 55-74; and (iii) once-only flexible sigmoidoscopy (FSIG) at age 60. A state-transition model was used to estimate costs and outcomes for each screening scenario vs no screening. A third party payer perspective was adopted. Probabilistic sensitivity analyses were undertaken. All scenarios would be considered highly cost-effective compared with no screening. The lowest incremental cost-effectiveness ratio (ICER vs no screening euro 589 per quality-adjusted life-year (QALY) gained) was found for FSIG, followed by FIT euro 1696) and gFOBT (euro 4428); gFOBT was dominated. Compared with FSIG, FIT was associated with greater gains in QALYs and reductions in lifetime cancer incidence and mortality, but was more costly, required considerably more colonoscopies and resulted in more complications. Results were robust to variations in para...Continue Reading

Associated Clinical Trials

References

Aug 18, 1993·Journal of the National Cancer Institute·S J WinawerD G Miller
Jan 18, 1996·The New England Journal of Medicine·J E AllisonA L Adrain
Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D G Fryback, W F Lawrence
May 2, 2001·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·H NakamaX Zhang
Sep 1, 2001·The New England Journal of Medicine·D A LiebermanUNKNOWN Veterans Affairs Cooperative Study Group 380
Apr 20, 2002·Lancet·W S AtkinUNKNOWN UK Flexible Sigmoidoscopy Screening Trial Investigators
Sep 11, 2002·Gut·W S AtkinUNKNOWN Association of Coloproctology for Great Britain and Ireland
Feb 6, 2003·Journal of the National Cancer Institute·Nicolle M GattoAlfred I Neugut
Jul 17, 2003·International Journal of Technology Assessment in Health Care·David K WhynesWendy S Atkin
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Sasieni
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J-L BulliardF Levi
Jan 22, 2004·European Journal of Health Law·UNKNOWN Council of Europe. Committee of Ministers
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Peter B CottonHarold Butler
Jul 23, 2004·The New England Journal of Medicine·Deborah Schrag
Jan 20, 2005·Annals of Internal Medicine·Judith F CollinsUNKNOWN Veterans Affairs Cooperative Study #380 Group
Apr 20, 2005·Annals of Internal Medicine·Brian P MulhallJeffrey L Jackson
Feb 4, 2006·The American Journal of Gastroenterology·Jeroen C van RijnEvelien Dekker
Oct 17, 2006·Minimally Invasive Neurosurgery : MIN·T NishizakiI C Gibbs
Nov 3, 2006·The New England Journal of Medicine·Jaroslaw RegulaEugeniusz Butruk
Jan 6, 2007·Histopathology·M J Mäkinen
Jan 27, 2007·The Cochrane Database of Systematic Reviews·P HewitsonE Watson
Jul 10, 2007·The American Journal of Gastroenterology·Tamiya MorikawaYasushi Shiratori
Jul 14, 2007·Journal of Medical Screening·Mercè PerisUNKNOWN Catalan Colorectal Cancer Screening Pilot Programme Group
Sep 27, 2007·Journal of the National Cancer Institute·James E AllisonJoseph V Selby
Jun 19, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Cheryl J PendergrassFrancis M Giardiello
Sep 19, 2008·The New England Journal of Medicine·C Daniel JohnsonPaul J Limburg

❮ Previous
Next ❯

Citations

Nov 1, 2015·Archives of Pathology & Laboratory Medicine·Amber L CrouseChristopher Naugler
Jun 8, 2017·Scandinavian Journal of Gastroenterology·Olle SjöströmBeatrice Melin
Nov 19, 2014·International Journal of Cancer. Journal International Du Cancer·Ulrike HaugKaren M Kuntz
Mar 28, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alan Ó CéilleachairLinda Sharp
Jul 31, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Paal JorangerEline Aas
Mar 29, 2019·Tumori·Manuel ZorziUNKNOWN AIRTUM Working Group
Feb 9, 2013·British Journal of Cancer·J F O'Mahony
Feb 9, 2013·British Journal of Cancer·L SharpH Comber
Nov 20, 2014·Digestive Diseases and Sciences·Inés CastroUNKNOWN COLONPREV study investigators
Nov 16, 2013·Health Economics Review·Kim E Jeong, John A Cairns
Sep 13, 2017·Health Technology Assessment : HTA·Tristan SnowsillChris Hyde
May 18, 2020·Journal of the American Medical Informatics Association : JAMIA·Heather SmithCraig Kuziemsky
Dec 10, 2013·Diseases of the Colon and Rectum·R PandeC Harmston
Jun 7, 2019·Journal of Global Oncology·Gregory C KnappT Peter Kingham
Aug 21, 2015·International Journal of Cancer. Journal International Du Cancer·Martin C S WongJoseph J Y Sung
Sep 29, 2020·Risk Management and Healthcare Policy·Farhad KhaliliAli Motlagh
Jan 15, 2016·The Medical Journal of Australia·Fraser BrimsKwun Fong
Nov 7, 2018·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Michael SchlanderTao Ran
Dec 20, 2012·The International Journal of Biological Markers·Louis W C ChowElizabeth L Y Ng
Jun 20, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Melissa McLeodTony Blakely

❮ Previous
Next ❯

Software Mentioned

gFOBT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
B DenisPhilippe Perrin
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Lieke HolErnst J Kuipers
© 2022 Meta ULC. All rights reserved